Research Focus

We are committed to expanding other tubulin payloads with enriched biophysical properties when they are conjugated with the antibody. We are also capable of developing novel conjugation technologies for better and safer drug release. Our robust and long-term research roadmap extends to advancing tubulysin as a standalone agent for ADCs.